Distinct facets of impulsivity exhibit differential associations with substance use disorder treatment processes: a cross-sectional and prospective investigation among military veterans

Journal of Substance Abuse Treatment
Adrienne J HeinzDaniel Blonigen

Abstract

Impulsivity, a multi-faceted construct characterized by rash, unplanned actions and a disregard for long-term consequences, is associated with poor substance use disorder (SUD) treatment outcomes. Little is known though about the influence of impulsivity on treatment process variables critical for initiating and maintaining behavioral change. This knowledge gap is important as different aspects of impulsivity may be susceptible to diverse cognitive, behavioral and pharmacological influences. The present study examined two distinct facets of impulsivity (lack of planning and immoderation--a proxy of urgency) as predictors of processes that impact SUD treatment success (active coping, avoidant coping, self-efficacy, and interpersonal problems). Participants were 200 Veterans who completed impulsivity and treatment process assessments upon entering an SUD treatment program and treatment process assessments at treatment discharge. Results from multivariate models revealed that lack of planning was associated with lower active coping and higher avoidant coping and interpersonal problems at intake, though not with lower self-efficacy to abstain from substances. Immoderation was associated with higher avoidant coping and lower self-ef...Continue Reading

References

Jan 1, 1992·Journal of Substance Abuse Treatment·A T McLellanM Argeriou
Dec 1, 1993·Archives of General Psychiatry·M M LinehanH E Armstrong
Oct 1, 1996·The Journal of Nervous and Mental Disease·J R McKayA I Alterman
Nov 7, 1999·Psychopharmacology·J L Evenden
Dec 20, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·G F Koob, M Le Moal
Nov 3, 2001·The American Journal of Psychiatry·F G MoellerA C Swann
Jan 5, 2002·Journal of Substance Abuse Treatment·F G MoellerJ Grabowski
Mar 9, 2002·The Journal of Neuropsychiatry and Clinical Neurosciences·William RinnDavid R Gastfriend
Jun 12, 2002·Psychological Assessment·Christopher J PatrickAuke Tellegen
Feb 28, 2003·The Clinical Neuropsychologist·Doug Johnson-GreeneLarry Junck
Aug 28, 2003·Experimental and Clinical Psychopharmacology·Stephen P Whiteside, Donald R Lynam
Jul 1, 2004·Neuroscience and Biobehavioral Reviews·Sharon Dawe, Natalie J Loxton
Jan 6, 2005·Journal of Personality and Social Psychology·Kristian E MarkonDavid Watson
Jan 1, 1997·International Journal of Behavioral Medicine·C S Carver
Oct 28, 2005·Nature Neuroscience·Barry J Everitt, Trevor W Robbins
Nov 30, 2006·Drug and Alcohol Dependence·Rudolf H Moos
Jan 27, 2007·Clinical Psychology Review·Rudolf H Moos
May 17, 2007·Assessment·Gregory T SmithDenis M McCarthy
Jun 15, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Chris C StreeterDeborah A Yurgelun-Todd
Jul 17, 2007·Drug and Alcohol Dependence·Antonio Verdejo-GarcíaMiguel Pérez-García
Oct 10, 2007·Behaviour Research and Therapy·Michael D AnestisThomas E Joiner
Oct 29, 2008·Psychological Bulletin·Melissa A Cyders, Gregory T Smith
Mar 31, 2009·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Arthur W Blume, G Alan Marlatt
May 5, 2009·Pharmacology, Biochemistry, and Behavior·Fulton Timm Crews, Charlotte Ann Boettiger
Feb 13, 2010·Addiction Biology·Danielle M DickKenneth Sher
Dec 15, 2010·European Addiction Research·M AraguesG Rubio
Jan 12, 2011·Psychological Bulletin·Catharine P CrossAnne Campbell
Nov 4, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Sophia VinogradovEtienne de Villers-Sidani
May 17, 2012·Assessment·Aidan G C WrightRobert F Krueger
Apr 13, 2013·Alcoholism, Clinical and Experimental Research·Ayca CoskunpinarMelissa A Cyders
Dec 5, 2013·Drug and Alcohol Review·Sarah LarneyLouisa Degenhardt
Jan 29, 2014·Drug and Alcohol Review·Sandra C Jones, Christopher A Magee
May 23, 2014·Journal of Personality Disorders·Trevor F WilliamsChristopher J Hopwood
May 24, 2014·Journal of Substance Abuse Treatment·Matthew Tyler BodenJodie Trafton

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.